These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8882648)

  • 1. Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein.
    Staropoli I; Clément JM; Frenkiel MP; Hofnung M; Deubel V
    J Virol Methods; 1996 Feb; 56(2):179-89. PubMed ID: 8882648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.
    Delenda C; Frenkiel MP; Deubel V
    Arch Virol; 1994; 139(1-2):197-207. PubMed ID: 7826210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice.
    Delenda C; Staropoli I; Frenkiel MP; Cabanié L; Deubel V
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1569-78. PubMed ID: 8021588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.
    Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C
    Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice.
    Kelly EP; Greene JJ; King AD; Innis BL
    Vaccine; 2000 May; 18(23):2549-59. PubMed ID: 10775789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.
    Feighny R; Burrous J; Putnak R
    Am J Trop Med Hyg; 1994 Mar; 50(3):322-8. PubMed ID: 8147490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice.
    Simmons M; Nelson WM; Wu SJ; Hayes CG
    Am J Trop Med Hyg; 1998 May; 58(5):655-62. PubMed ID: 9598457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
    Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
    Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
    Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
    J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
    Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
    Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses.
    Deubel V; Bordier M; Megret F; Gentry MK; Schlesinger JJ; Girard M
    Virology; 1991 Jan; 180(1):442-7. PubMed ID: 1984665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system.
    Bielefeldt-Ohmann H; Beasley DW; Fitzpatrick DR; Aaskov JG
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2723-33. PubMed ID: 9367357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis.
    Niu G; Pang Z; Guan C; Qi J; Li D
    Virus Res; 2015 Apr; 201():73-8. PubMed ID: 25697685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice.
    Staropoli I; Frenkiel MP; Mégret F; Deubel V
    Vaccine; 1997 Dec; 15(17-18):1946-54. PubMed ID: 9413106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fragment of the envelope protein from dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice.
    Hermida L; Rodríguez R; Lazo L; Bernardo L; Silva R; Zulueta A; López C; Martín J; Valdés I; del Rosario D; Guillén G; Guzmán MG
    Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):107-14. PubMed ID: 12887334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice.
    Coconi-Linares N; Ortega-Dávila E; López-González M; García-Machorro J; García-Cordero J; Steinman RM; Cedillo-Barrón L; Gómez-Lim MA
    Vaccine; 2013 May; 31(19):2366-71. PubMed ID: 23499580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Megret F; Hugnot JP; Falconar A; Gentry MK; Morens DM; Murray JM; Schlesinger JJ; Wright PJ; Young P; Van Regenmortel MH
    Virology; 1992 Apr; 187(2):480-91. PubMed ID: 1372140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection.
    Srivastava AK; Putnak JR; Warren RL; Hoke CH
    Vaccine; 1995 Sep; 13(13):1251-8. PubMed ID: 8578812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.